Moran Sean F. — SEC Form 4 filings
SEC reporting owner CIK 1451495. 9 Form 4 filings on record with FilingPulse; latest filed 2026-08-10.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-14 to 2026-08-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 5 filings — 50,517 shares, $1,266,779 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: sale of 7,788 shares @ $49.87 ($388,417) in Corbus Pharmaceuticals Holdings, Inc., filed 2024-06-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Chief Financial Officer | 9 | — | 8 legs · 50,517 sh · $1,266,779 | 18 |
Form 4 filings — Moran Sean F.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-10 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Sale (S): 12,000 @ $10.08 | EDGAR |
| 2026-02-18 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Sale (S): 4,701 @ $7.78 | EDGAR |
| 2026-01-16 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Grant/award (A): 28,082 @ $0 · Grant/award (A): 84,247 (derivative) @ $0 | EDGAR |
| 2025-10-27 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Option exercise (M): 12,981 @ $4.26 · Sale (S): 12,981 @ $17.02 · Option exercise (M): 12,981 (derivative) @ $0 | EDGAR |
| 2025-02-18 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Sale (S): 2,792 @ $8.76 | EDGAR |
| 2025-02-04 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Grant/award (A): 27,500 @ $0 · Grant/award (A): 92,500 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Option exercise (M): 1,567 @ $30 · Sale (S): 1,567 @ $49.87 · Option exercise (M): 7,788 @ $4.26 · Sale (S): 7,788 @ $49.87 · Option exercise (M): 6,730 @ $14.10 · Sale (S): 6,730 @ $46.77 · +6 more | EDGAR |
| 2024-04-11 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Option exercise (M): 1,787 @ $30 · Option exercise (M): 1,787 (derivative) @ $0 | EDGAR |
| 2024-02-14 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Grant/award (A): 40,176 @ $0 · Grant/award (A): 40,176 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1451495 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →